Australia markets closed

Innovent Biologics, Inc. (1801.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
40.050+0.250 (+0.63%)
At close: 04:08PM HKT
Currency in HKD
Earnings estimateCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2024)Next year (2025)
No. of analysts002624
Avg. Estimate00-0.550.08
Low estimate00-0.87-0.29
High estimate00-0.220.71
Year ago EPSN/AN/A-0.73-0.55
Revenue estimateCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2024)Next year (2025)
No. of analysts2702727
Avg. Estimate8.23BN/A8.23B10.81B
Low estimate7.4BN/A7.4B8.58B
High estimate8.67BN/A8.67B12.95B
Year ago sales6.85BN/A6.85B8.23B
Sales growth (year/est)20.10%N/A20.10%31.40%
Earnings historyInvalid DateInvalid DateInvalid DateInvalid Date
Est. EPSN/AN/AN/AN/A
Actual EPSN/AN/AN/AN/A
DifferenceN/AN/AN/AN/A
Surprise %N/AN/AN/AN/A
EPS trendCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2024)Next year (2025)
Current estimate00-0.550.08
7 days ago00-0.550.08
30 days ago00-0.590.05
60 days ago00-0.580.29
90 days ago00-0.550.29
EPS revisionsCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/A1
Up last 30 daysN/AN/A33
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A1N/A
Growth estimates1801.HKIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year24.70%N/AN/AN/A
Next year114.50%N/AN/AN/A
Next 5 years (per annum)-46.42%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A